|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02410 TYK MEDICINES-B
Nominal 
11.110 +0.920 (+9.028%) Non-current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Investment Properties | -- | -- | 0 | 0 | 0 |
| Property, plant, equip. & others | -- | -- | 159,575 | 157,510 | 82,648 |
| Land & other Lease Assets | -- | -- | 50,260 | 92,335 | 107,548 |
| Intangible Assets | -- | -- | 62,412 | 68,071 | 73,730 |
| Interests in Asso. & JCEs | -- | -- | 0 | 0 | 0 |
| Other Non-current Assets | -- | -- | 74,471 | 21,513 | 19,705 |
| -- | -- | 346,718 | 339,429 | 283,631 | |
Current Assets
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Inventories | -- | -- | 0 | 0 | 0 | |
| Trade Receivables | -- | -- | 0 | 0 | 0 | |
| Cash & Bank Balances | -- | -- | 460,463 | 186,830 | 90,762 | |
| Other Current Assets | -- | -- | 76,175 | 46,879 | 183,968 | |
| Assets Held for Sale | -- | -- | 32,337 | 0 | 0 | |
| -- | -- | 568,975 | 233,709 | 274,730 | ||
Current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||
| Trade Payables | -- | -- | 19,642 | 32,167 | 9,664 | ||
| S-T Debt & Leases | -- | -- | 170,363 | 22,226 | 23,492 | ||
| Other Current Liabilities | -- | -- | 99,064 | 1,246,586 | 929,084 | ||
| Liab asso w/ Assets Held for Sale | -- | -- | 12 | 0 | 0 | ||
| -- | -- | 289,081 | 1,300,979 | 962,240 | |||
| Net Current Assets | -- | -- | 279,894 | (1,067,270) | (687,510) | ||
| Total Assets Less Current Liabilities | -- | -- | 626,612 | (727,841) | (403,879) | ||
Non-current Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||||
| L-T Debt & Leases | -- | -- | 6,485 | 19,503 | 32,458 | |||
| Other Non-current Liabilities | -- | -- | 147,565 | 132,689 | 64,412 | |||
| -- | -- | 154,050 | 152,192 | 96,870 | ||||
Capital and Reserves
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |||||
| Share Capital | -- | -- | 370,836 | 307,356 | 287,989 | ||||
| Reserves | -- | -- | 98,252 | (1,191,836) | (793,929) | ||||
| Others | -- | -- | 0 | 0 | 0 | ||||
| Shareholders' Funds | -- | -- | 469,088 | (884,480) | (505,940) | ||||
| Non-controlling Interests | -- | -- | 3,474 | 4,447 | 5,191 | ||||
| Others | -- | -- | 0 | 0 | 0 | ||||
| -- | -- | 472,562 | (880,033) | (500,749) | |||||
Commitments and Contingent Liabilities
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Commitments | -- | -- | 36,433 | 15,540 | 12,393 |
| Contingent Liabilities | -- | -- | 0 | 0 | 0 |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -299,768 |
| %Change | -22.532% |
| EPS / (LPS) | RMB -0.800 |
| NBV Per Share (¥) | RMB -- |